The healthcare sector has struggled to deliver worthwhile returns for investors since 2021, weighed down by several headwinds ...

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs ...

Brokerages Motilal Oswal and Jefferies have maintained positive outlooks for ICICI Bank, Torrent Pharmaceuticals, and Godrej ...

For the uninitiated, Recursion wants to become the go-to provider of AI-based drug discovery and development services for the ...

This was largely due to a strong surge in IT and pharmaceutical stocks that improved market sentiment. However, declines in ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...

Mirum Pharmaceuticals, Inc. (MIRM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are ...

Attruby's approval makes BridgeBio Pharma a competitor to Vyndaqel, with significant potential for growth and milestone ...